{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T10:22:29Z","timestamp":1707128549279},"reference-count":24,"publisher":"Scientific Scholar","content-domain":{"domain":["nmji.in"],"crossmark-restriction":true},"short-container-title":["NMJI"],"abstract":"<jats:sec id=\"st1\">\n<jats:title>Background<\/jats:title>\n<jats:p>In May 2020, WHO recognized the role of extensive immunization for interrupting the transmission of the SARS-CoV-2 virus. The development of such vaccines in clinical trials relies upon participants who are expected to be vested in the research process. Assessment of participant factors such as motivation and satisfaction are hence important to gauge perspective and ensure successful conduct and completion of these trials.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st2\">\n<jats:title>Methods<\/jats:title>\n<jats:p>We administered a validated three-domain questionnaire to and documented the binary categorical responses (yes\/no) of participants (after informed consent) who had taken both doses of COVOVAX\u2122 in a phase 3 trial at our institute. Association of the dependent variables (participant responses) with the independent variables (participant demographics and socioeconomic strata) was computed using Chi-square test at 5% significance. In case of a significant association, Bonferroni post-hoc test was applied for multiple comparisons.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st3\">\n<jats:title>Results<\/jats:title>\n<jats:p>Of the 78 participants who were administered the questionnaire, two-thirds were highly satisfied with their experience at our site. Gaining access to a new vaccine was a primary motivation overall (74%) and also in graduates (p=0.03) and middle-class population (p=0.002), whereas the lower-middle class population (p&lt;0.0001) and those educated till secondary school (p=0.003) took part due to the long wait for government-approved vaccines.<\/jats:p>\n<\/jats:sec>\n<jats:sec id=\"st4\">\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Participants in a Covid-19 vaccine trial at Mumbai were largely satisfied with the care given to them though altruism did not feature as a primary reason for participation.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/nmji_496_22","type":"journal-article","created":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:47:25Z","timestamp":1672847245000},"page":"214-218","update-policy":"http:\/\/dx.doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of satisfaction and reasons for participation in a Covid-19 vaccine clinical trial: A single-centre, observational study"],"prefix":"10.25259","volume":"35","author":[{"given":"PALVI","family":"KUDYAR","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"DHRUVE","family":"SONI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"NITHYA J.","family":"GOGTAY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10894","published-online":{"date-parts":[[2023,1,3]]},"reference":[{"key":"10.25259\/NMJI_496_22\/ref-1","first-page":"93","article-title":"The COVID-19 vaccination acceptance\/hesitancy rate and its determinants among healthcare workers of 91 countries: A multicenter cross-sectional study","volume":"21","author":"Askarian","year":"2022","journal-title":"EXCLI J"},{"key":"10.25259\/NMJI_496_22\/ref-3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1017\/cts.2020.20","article-title":"Satisfaction and perceptions of research participants in clinical and translational studies: An urban multi-institution with CTSA","volume":"4","author":"Adler","year":"2020","journal-title":"J Clin Transl Sci"},{"key":"10.25259\/NMJI_496_22\/ref-4","first-page":"42","article-title":"Implementation of a research participant satisfaction survey at an academic medical center","volume":"30","author":"Smailes","year":"2016","journal-title":"Clin Res (Alex)"},{"key":"10.25259\/NMJI_496_22\/ref-6","doi-asserted-by":"publisher","first-page":"154","DOI":"10.4103\/jiaphd.jiaphd_52_21","article-title":"Updated BG Prasad Socioeconomic status classification for the year 2021","volume":"19","author":"Khairnar","year":"2021","journal-title":"J Indian Assoc Public Health Dent"},{"key":"10.25259\/NMJI_496_22\/ref-8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.47203\/IJCH.2020.v32i01.024","article-title":"Modified BG Prasad Socio-economic Classification updated-2020","volume":"32","author":"Debnath","year":"2020","journal-title":"Indian J Comm Health"},{"key":"10.25259\/NMJI_496_22\/ref-9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1001\/jama.289.4.397","article-title":"Sex and gender factors in medical studies: Implications for health and clinical practice","volume":"289","author":"Pinn","year":"2003","journal-title":"JAMA"},{"key":"10.25259\/NMJI_496_22\/ref-10","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.medj.2021.04.010","article-title":"Progress and opportunities for women in clinical trials: A look at recent data and initiatives from the US FDA","volume":"2","author":"Vasisht","year":"2021","journal-title":"Med"},{"key":"10.25259\/NMJI_496_22\/ref-11","doi-asserted-by":"publisher","first-page":"2113749","DOI":"10.1001\/jamanetworkopen.2021.13749","article-title":"Analysis of female enrolment and participant sex by burden of disease in US clinical trials between 2000 and 2020","volume":"4","author":"Steinberg","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.25259\/NMJI_496_22\/ref-12","doi-asserted-by":"publisher","first-page":"93","DOI":"10.4103\/picr.PICR_97_19","article-title":"A survey of knowledge and variables influencing perceptions about clinical research: A cross-sectional study from Mumbai","volume":"12","author":"Figer","year":"2021","journal-title":"Perspect Clin Res"},{"key":"10.25259\/NMJI_496_22\/ref-13","doi-asserted-by":"publisher","first-page":"608959","DOI":"10.3389\/fmed.2021.608959","article-title":"Factors influencing participation in COVID-19 clinical trials: A multi-national study","volume":"8","author":"Abdelhafiz","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.25259\/NMJI_496_22\/ref-14","doi-asserted-by":"publisher","first-page":"184","DOI":"10.4103\/2229-3485.167099","article-title":"Elderly patients' participation in clinical trials","volume":"6","author":"Shenoy","year":"2015","journal-title":"Perspect Clin Res"},{"key":"10.25259\/NMJI_496_22\/ref-15","doi-asserted-by":"publisher","first-page":"e317","DOI":"10.1016\/S2214-109X(21)00546-5","article-title":"Challenges in operationalising clinical trials in India during the COVID-19 pandemic","volume":"10","author":"Bassi","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.25259\/NMJI_496_22\/ref-16","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1001\/jama.292.13.1593","article-title":"Interventions to improve research participants understanding in informed consent for research: A systemic review","volume":"292","author":"Flory","year":"2004","journal-title":"JAMA"},{"key":"10.25259\/NMJI_496_22\/ref-17","doi-asserted-by":"publisher","first-page":"e711","DOI":"10.1016\/S2214-109X(20)30542-8","article-title":"How COVID-19 has fundamentally changed clinical research in global health","volume":"9","author":"Park","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.25259\/NMJI_496_22\/ref-18","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1038\/s41541-021-00327-2","article-title":"Strategy for COVID-19 vaccination in India: The country with the second highest population and number of cases","volume":"6","author":"Kumar","year":"2021","journal-title":"NPJ Vaccines"},{"key":"10.25259\/NMJI_496_22\/ref-19","doi-asserted-by":"publisher","first-page":"994","DOI":"10.1186\/s12913-021-07037-4","article-title":"Attitude towards COVID 19 vaccines and vaccine hesitancy in urban and rural communities in Tamil Nadu, India: A community based survey","volume":"21","author":"Danabal","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.25259\/NMJI_496_22\/ref-20","doi-asserted-by":"publisher","first-page":"2007","DOI":"10.2147\/PPA.S206728","article-title":"Factors influencing participation of healthy volunteers in clinical trials: Findings from a cross-sectional study in Delhi, North India","volume":"13","author":"Ranjan","year":"2019","journal-title":"Patient Prefer Adherence"},{"key":"10.25259\/NMJI_496_22\/ref-21","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/S0959-8049(00)00191-X","article-title":"Information and communication in the context of a clinical trial","volume":"36","author":"Hietanen","year":"2000","journal-title":"Eur J Cancer"},{"key":"10.25259\/NMJI_496_22\/ref-22","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/S0197-2456(00)00048-9","article-title":"A randomized trial assessing the impact of written information on outpatients' knowledge about and attitude toward randomized clinical trials. The INFO trial group","volume":"21","author":"Kruse","year":"2000","journal-title":"Control Clin Trials"},{"key":"10.25259\/NMJI_496_22\/ref-23","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1200\/JCO.2001.19.15.3554","article-title":"Randomized clinical trials in oncology: Understanding and attitudes predict willingness to participate","volume":"19","author":"Ellis","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.25259\/NMJI_496_22\/ref-24","doi-asserted-by":"publisher","first-page":"1772","DOI":"10.1016\/S0140-6736(01)06805-2","article-title":"Quality of informed consent in cancer clinical trials: A cross-sectional survey","volume":"358","author":"Joffe","year":"2001","journal-title":"Lancet"},{"key":"10.25259\/NMJI_496_22\/ref-25","doi-asserted-by":"publisher","first-page":"2110848","DOI":"10.1001\/jamanetworkopen.2021.10848","article-title":"Informed consent-We can and should do better","volume":"4","author":"Grant","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.25259\/NMJI_496_22\/ref-26","first-page":"3083","article-title":"Challenges facing COVID-19 vaccination in India: Lessons from the initial vaccine rollout","volume":"11","author":"Pandey","year":"2021","journal-title":"J Glob Health"},{"key":"10.25259\/NMJI_496_22\/ref-27","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1002\/nur.20259","article-title":"Is there a bias against telephone interviews in qualitative research?","volume":"31","author":"Novick","year":"2008","journal-title":"Res Nurs Health"}],"container-title":["The National Medical Journal of India"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/nmji.in\/evaluation-of-satisfaction-and-reasons-for-participation-in-a-covid-19-vaccine-clinical-trial-a-single-centre-observational-study\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/nmji.in\/evaluation-of-satisfaction-and-reasons-for-participation-in-a-covid-19-vaccine-clinical-trial-a-single-centre-observational-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,4]],"date-time":"2023-01-04T15:47:30Z","timestamp":1672847250000},"score":1,"resource":{"primary":{"URL":"https:\/\/nmji.in\/evaluation-of-satisfaction-and-reasons-for-participation-in-a-covid-19-vaccine-clinical-trial-a-single-centre-observational-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,3]]},"references-count":24,"alternative-id":["10.25259\/NMJI_496_22"],"URL":"https:\/\/doi.org\/10.25259\/nmji_496_22","relation":{},"ISSN":["0970-258X"],"issn-type":[{"value":"0970-258X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,3]]},"article-number":"214"}}